Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver diseaseZoe Boyer‐Díaz, Jordi Gracia‐Sancho, Pierre Broqua et al.|Journal of Hepatology|2020Cited by 163
The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for CancerAlbert Gibert‐Ramos, Anabel Fernández‐Iglesias, David Sanfeliu-Redondo et al.|Cancers|2021Cited by 39
A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver DiseaseZoe Boyer‐Díaz, Jordi Gracia‐Sancho, Jaime Bosch et al.|Nutrients|2019Cited by 22
4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat liversAnabel Fernández‐Iglesias, Jordi Gracia‐Sancho|Journal of Cellular and Molecular Medicine|2018Cited by 20